4.5 Article

Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer

Journal

Publisher

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/cshperspect.a028530

Keywords

-

Categories

Funding

  1. National Health and Medical Research Council of Australia (NHMRC)
  2. Cancer Council of Queensland (CCQ)
  3. University of Queensland International Scholarship
  4. Queensland Institute of Medical Research (QIMR) Berghofer International Scholarship

Ask authors/readers for more resources

The balance of proinflammatory cytokines interleukin (IL)-12 and IL-23 plays a key role in shaping the development of antitumor or protumor immunity. In this review, we discuss the role IL-12 and IL-23 plays in tumor biology from preclinical and clinical data. In particular, we discuss the mechanism by which IL-23 promotes tumor growth and metastases and how the IL-12/IL-23 axis of inflammation can be targeted for cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available